The biggest US tech stocks have enjoyed an earnings bonanza in the past two years, leading to their significant ...

A new U.K. study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

Children are at greater risk for frost-bite than adults. The best way to prevent frostbite is to make sure children dress ...

For patients with severe elevations in low-density lipoprotein (LDL) cholesterol (≥190 mg/dL) and a combination of clinical ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel, first-in-class biologic therapy ...

Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 - - SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expec ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

A consumer research journal has reviewed all 50 states to determine which are the best ones for parents to rear their ...

The Pediatric Care Center has since evolved into the Ann Storck Center, which runs a preschool and elementary school for ...

McKee, in his second year out of Stanford, threw two more touchdown passes after replacing Pickett and then made his first ...

LONDON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, ...